MedTrace Logo

Personalized Medicine in Patients With Infective Endocarditis

NCT04838938 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 32

Last updated 2023-10-05

No results posted yet for this study

Summary

The hypothesis underlying this work is the identification of different sub phenotypes of patients with infective endocarditis through the study of the host's response to infection.

Furthemore, metagenomic sequencing may be a helpful supplement to IE diagnostic, especially when conventional tests fail to yield a diagnosis.

Conditions

  • Infective Endocarditis
  • Response, Acute Phase
  • Treatment

Sponsors & Collaborators

  • Fundación para la Investigación Biosanitaria del Principado de Asturias

    lead OTHER

Principal Investigators

  • Guillermo Muñiz Albaiceta, MD, PhD · HUCA-FINBA, Universidad de Oviedo

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-03-01
Primary Completion
2022-03-01
Completion
2023-07-01

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04838938 on ClinicalTrials.gov